Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (221-230 of 2,087) with videos related to

Pageof 209
Sort By:
RMD Open|January 26, 2021
Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilarJuliette Petit, Marie Antignac, Rose-Marie Poilverd, et al.
RMD Open|January 29, 2021
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registryClaudia Diniz Lopes Marques, Adriana Maria Kakehasi, Marcelo Medeiros Pinheiro, et al.
RMD Open|January 29, 2021
Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritisIsabelle Bonnet, Antoine Rousseau, Pierre Duraffour, et al.
RMD Open|January 16, 2021
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combinationVibeke Strand, Philip J Mease, Ervant J Maksabedian Hernandez, et al.
RMD Open|January 16, 2021
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritisJon T Giles, Alexis Ogdie, Juan J Gomez Reino, et al.
RMD Open|November 17, 2021
Reexamining remission definitions in rheumatoid arthritis: considering the twenty-eight-joint Disease Activity Score, C-reactive protein level and patient global assessmentDavid Felson, Diane Lacaille, Michael P LaValley, et al.
RMD Open|November 9, 2021
Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA studyClementina López-Medina, Sylvie Chevret, Anna Molto, et al.
RMD Open|March 9, 2021
Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trialLaurette van Boheemen, Samina Turk, Marian van Beers-Tas, et al.
RMD Open|March 10, 2021
Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndromeAnastasia Dupré, Juliette Pascaud, Elodie Rivière, et al.
RMD Open|January 30, 2021
Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritisNadia M T Roodenrijs, Melinda Kedves, Attila Hamar, et al.
Pageof 209

Showing results (221-230 of 2,087) with videos related to

Sort By:
Pageof 209
RMD Open|January 26, 2021
Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilarJuliette Petit, Marie Antignac, Rose-Marie Poilverd, et al.
RMD Open|January 29, 2021
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registryClaudia Diniz Lopes Marques, Adriana Maria Kakehasi, Marcelo Medeiros Pinheiro, et al.
RMD Open|January 29, 2021
Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritisIsabelle Bonnet, Antoine Rousseau, Pierre Duraffour, et al.
RMD Open|January 16, 2021
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combinationVibeke Strand, Philip J Mease, Ervant J Maksabedian Hernandez, et al.
RMD Open|January 16, 2021
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritisJon T Giles, Alexis Ogdie, Juan J Gomez Reino, et al.
RMD Open|November 17, 2021
Reexamining remission definitions in rheumatoid arthritis: considering the twenty-eight-joint Disease Activity Score, C-reactive protein level and patient global assessmentDavid Felson, Diane Lacaille, Michael P LaValley, et al.
RMD Open|November 9, 2021
Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA studyClementina López-Medina, Sylvie Chevret, Anna Molto, et al.
RMD Open|March 9, 2021
Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trialLaurette van Boheemen, Samina Turk, Marian van Beers-Tas, et al.
RMD Open|March 10, 2021
Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndromeAnastasia Dupré, Juliette Pascaud, Elodie Rivière, et al.
RMD Open|January 30, 2021
Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritisNadia M T Roodenrijs, Melinda Kedves, Attila Hamar, et al.
Pageof 209